HealthCare Global Enterprises Limited
HCG.NS · National Stock Exchange of India · INR
572,00INR
−16,35 (−2,78 %)Stand 11. Nov., 9:59
Kennzahlen
- Eröffnung
- 585,10
- Vortag
- 588,35
- Tagesspanne
- 555,25 – 598,95
- 52 Wochen
- 513,30 – 775,00
- Volumen
- 258.821
- Ø Volumen
- 176.658
- Börsenwert
- 85,4 Mrd. INR
- KGV
- –
- Gewinn je Aktie (TTM)
- –
- Dividendenrendite
- –
- Beta
- -0,0
- Nächste Zahlen
- –
Finanzen
Gerade nicht verfügbar.
Bewertung
Gerade nicht verfügbar.
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Quartalszahlen
Gerade nicht verfügbar.
Dividenden und Splits
Gerade nicht verfügbar.
Aktiensplits
Gerade nicht verfügbar.
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
Gerade nicht verfügbar.
Vergleichbare Unternehmen
Gerade nicht verfügbar.
Über das Unternehmen
HealthCare Global Enterprises Limited, founded in 1989 and headquartered in Bengaluru, India, delivers comprehensive healthcare services with a primary focus on oncology. The company offers a full spectrum of cancer care, from diagnosis to various treatment modalities such as radiation therapy, medical oncology, and surgical procedures. Beyond its core cancer services, HCG also operates in the field of fertility and reproductive medicine under its Milann brand. This includes services like assisted reproduction, gynecological endoscopy, and fertility preservation. The enterprise further manages four multi-specialty hospitals: three branded HCG facilities located in Ahmedabad, Bhavnagar, and Rajkot in Gujarat, and one in Hubli, Karnataka, operated under a management contract. These hospitals cater to diverse medical specialities including cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, pulmonary care, and critical care. Additionally, HealthCare Global provides medical diagnostic services, offering scientific testing and consultancy for the pharmaceutical and broader medical industries. As of March 31, 2021, its extensive network comprised 23 cancer centers throughout India, featuring a center of excellence in Bengaluru, alongside two independent diagnostic centers and one day-care chemotherapy unit. The company also maintains an international presence with a cancer center established in Africa.
- CEO
- Manish Mattoo
- Mitarbeitende
- 6.761
- Hauptsitz
- Bengaluru, KA, IN
- Sektor
- Healthcare
- Branche
- Medical - Care Facilities
- Börsengang
- 31. März 2016
- Website
- hcgoncology.com
Nachrichten
Gerade nicht verfügbar.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.